Prilosec OTC Leads Stomach Remedy Market; Consumer Use Data Published
This article was originally published in The Tan Sheet
Executive Summary
Prilosec OTC leads the nonprescription stomach remedy market in food and drug channels with a 17% dollar share after roughly three months on the market, based on AC Nielsen data, Procter & Gamble said
You may also be interested in...
Mylan Says OTC, Rx Prilosec Not Bioequivalent In Study
Prilosec OTC is not bioequivalent to prescription Prilosec under the conditions of a small clinical study recently submitted to FDA by Mylan Labs, according to the firm
Prilosec OTC Success Has P&G Eyeing Pharma Partner For Next Switch Drug
Procter & Gamble is keeping its ear to the ground for partnerships with major prescription drug players in search of the next big Rx-to-OTC switch following the successful launch of Prilosec OTC in September
Prilosec 1 Use For GERD Endorsed In 16-2 Joint Committee Vote
Possible long-term use of omeprazole to prevent chronic heartburn or gastroesophageal reflux disease (GERD) is acceptable, despite an OTC indication for only 14-day use, FDA advisory committee members determined at a meeting in Bethesda, Md. June 21